InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ALX ONCOLOGY HOLDINGS INC

ALXO Clue Score32
United States Fiscal year ends December CIK 0001810182
$1.25 +5.93% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.25 −97.96% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 17 Jul 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2018Revenue2.1Operating income−13.7Net income−13.7Fiscal year 2019Revenue4.8 +132.0%Operating income−19.2Net income−19.2Fiscal year 2020Revenue1.2 −75.4%Operating income−43.7Net income−45.7EPS, diluted−2.76Fiscal year 2021Revenue0.0 −100.0%Operating income−83.6Net income−83.5EPS, diluted−2.07Fiscal year 2022Revenue0.0Operating income−127.4Net income−123.5EPS, diluted−3.03Fiscal year 2023Operating income−170.3Net income−160.8EPS, diluted−3.74Fiscal year 2024Operating income−142.5Net income−134.9EPS, diluted−2.58Fiscal year 2025Operating income−104.0Net income−101.7EPS, diluted−1.90
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 2.1 4.8 1.2 0.0 0.0 n/a n/a n/a
Growth +132.0% −75.4% −100.0%
Operating income −13.7 −19.2 −43.7 −83.6 −127.4 −170.3 −142.5 −104.0
Net income −13.7 −19.2 −45.7 −83.5 −123.5 −160.8 −134.9 −101.7
Growth
EPS, diluted n/a n/a −2.76 −2.07 −3.03 −3.74 −2.58 −1.90

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2018Operating margin−662.0%Net margin−664.3%Free cash flow margin−669.7%Fiscal year 2019Operating margin−400.0%Net margin−401.2%Free cash flow margin−304.5%Fiscal year 2020Operating margin−3,694.0%Net margin−3,869.7%Free cash flow margin−3,242.0%Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Fiscal year 2025
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −662.0% −400.0% −3,694.0% n/a n/a n/a n/a n/a
Net margin −664.3% −401.2% −3,869.7% n/a n/a n/a n/a n/a
Free cash flow margin −669.7% −304.5% −3,242.0% n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2018Operating cash flow−13.2Capital expenditure−0.7Free cash flow−13.8Buybacks−0.0Fiscal year 2019Operating cash flow−14.2Capital expenditure−0.4Free cash flow−14.6Fiscal year 2020Operating cash flow−38.3Capital expenditure−0.0Free cash flow−38.3Fiscal year 2021Operating cash flow−68.1Capital expenditure−0.7Free cash flow−68.8Fiscal year 2022Operating cash flow−89.2Capital expenditure−1.4Free cash flow−90.7Fiscal year 2023Operating cash flow−130.4Capital expenditure−1.3Free cash flow−131.6Fiscal year 2024Operating cash flow−121.9Capital expenditure−0.4Free cash flow−122.4Fiscal year 2025Operating cash flow−84.1Capital expenditure−0.2Free cash flow−84.4
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −13.2 −14.2 −38.3 −68.1 −89.2 −130.4 −121.9 −84.1
Capital expenditure −0.7 −0.4 −0.0 −0.7 −1.4 −1.3 −0.4 −0.2
Free cash flow −13.8 −14.6 −38.3 −68.8 −90.7 −131.6 −122.4 −84.4
Growth
Buybacks −0.0 n/a n/a n/a n/a n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2018Cash8.3Shareholders’ equity−51.8Fiscal year 2019Cash9.0Total debt5.4Net cash (debt)3.6Shareholders’ equity−70.6Fiscal year 2020Cash434.2Shareholders’ equity429.8Fiscal year 2021Cash363.7Shareholders’ equity363.0Fiscal year 2022Cash48.8Total debt9.4Net cash (debt)39.4Shareholders’ equity263.5Debt to equity0.04Fiscal year 2023Cash22.4Total debt9.6Net cash (debt)12.8Shareholders’ equity189.7Debt to equity0.05Fiscal year 2024Cash17.6Total debt9.9Net cash (debt)7.7Shareholders’ equity113.6Debt to equity0.09Fiscal year 2025Cash16.4Total debt9.7Net cash (debt)6.6Shareholders’ equity26.0Debt to equity0.38
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 8.3 9.0 434.2 363.7 48.8 22.4 17.6 16.4
Total debt n/a 5.4 n/a n/a 9.4 9.6 9.9 9.7
Net cash (debt) n/a 3.6 n/a n/a 39.4 12.8 7.7 6.6
Shareholders’ equity −51.8 −70.6 429.8 363.0 263.5 189.7 113.6 26.0
Debt to equity n/a n/a n/a n/a 0.04 0.05 0.09 0.38

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
−662.0% −400.0% −3,694.0% n/a n/a n/a n/a n/a
−662.1% −400.5% −3,849.3% n/a n/a n/a n/a n/a
−664.3% −401.2% −3,869.7% n/a n/a n/a n/a n/a
−669.7% −304.5% −3,242.0% n/a n/a n/a n/a n/a
Spending
545.2% 340.0% 2,450.2% n/a n/a n/a n/a n/a
125.8% 69.1% 1,252.9% n/a n/a n/a n/a n/a
31.6% 7.4% 2.6% n/a n/a n/a n/a n/a
Returns
n/a n/a −10.6% −23.0% −46.9% −84.8% −118.7% −391.4%
n/a −180.2% −10.5% −22.0% −40.3% −66.3% −91.3% −172.2%
Balance and payout
n/a n/a n/a n/a 0.04 0.05 0.09 0.38
n/a 102.6% 1.4% 4.5% 14.0% 21.8% 23.1% 56.0%